7-102813500-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000440067.4(FBXL13):c.2320C>A(p.Gln774Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000440067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL13 | NM_001394494.2 | c.2320C>A | p.Gln774Lys | missense_variant | 21/21 | ENST00000440067.4 | NP_001381423.1 | |
FBXL13 | NR_105043.2 | n.2269C>A | non_coding_transcript_exon_variant | 21/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL13 | ENST00000440067.4 | c.2320C>A | p.Gln774Lys | missense_variant | 21/21 | 3 | NM_001394494.2 | ENSP00000390126 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251310Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135818
GnomAD4 exome AF: 0.000141 AC: 206AN: 1461786Hom.: 0 Cov.: 30 AF XY: 0.000158 AC XY: 115AN XY: 727184
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.2050C>A (p.Q684K) alteration is located in exon 20 (coding exon 18) of the FBXL13 gene. This alteration results from a C to A substitution at nucleotide position 2050, causing the glutamine (Q) at amino acid position 684 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at